Chelsea Therapeutics (CHTP) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts CHTP Hot Sheet
Price: $6.52 --0%
Financial Fact:
Net loss per basic and diluted share of common stock: -0.1
Today's EPS Names:
ZVOI, SYRS, ATRA, More
Financial Fact:
Net loss per basic and diluted share of common stock: -0.1
Today's EPS Names:
ZVOI, SYRS, ATRA, More
Join SI Premium – FREE
Chelsea Therapeutics (NASDAQ: CHTP) reported Q2 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BrightSpring Health Services, Inc. (BTSG) Tops Q3 EPS by 34c ; Offers Guidance
- FST Corp. (KBSX) Reports In-Line Q3 EPS
- SPS Commerce (SPSC) Tops Q3 EPS by 16c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
